RedCo II Master Fund, L.P.
10% Owner

RedCo II Master Fund, L.P. insider trades: ADC Therapeutics (ADCT) stock buys and sales

10% Owner, ADC Therapeutics Last trade Apr 2, 2026 14 Form 4 filings
$19.6M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2023
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where RedCo II Master Fund, L.P. reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2026ADCT↓ Sell$10.0M
Apr 2, 2026ADCT↓ Sell$9.6M
Dec 11, 2024ADCT↑ Buy$305K
Dec 11, 2024ADCT↑ Buy$305K
Dec 4, 2024ADCT↓ Sell$52K
Jul 1, 2024ADCT↑ Buy$1.1M
Jul 1, 2024ADCT↑ Buy$1.1M
Nov 20, 2023AUGX↑ Buy$3.0M
Nov 20, 2023AUGX↑ Buy$3.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ADCT insiders

Open-market trades in the last 12 months

About RedCo II Master Fund, L.P.'s insider trades

RedCo II Master Fund, L.P. is a 10% owner of ADC Therapeutics (ADCT). Since Nov 20, 2023, it has reported 6 open-market purchases worth $8.9M and 3 sales worth $19.7M on SEC Form 4. In the last 12 months: 2 sales ($19.6M).

Its filings also include other transactions (6 filings), grants and awards (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.